Pharmacogenomics is the study of how variations in different genes can affect a person’s response to drugs. It is well recognized that most drugs do not produce the same effect in each individual. It can be difficult to predict who will benefit from a given therapy, who will not respond at all, and who will experience adverse drug reactions.

NewGene has made two pharmacogenomic tests available for routine clinical use; TPMT sensitivity and Warfarin sensitivity. This test portfolio will be added to as additional tests become available.

The company has several pharmacogenomic research projects in development; if you are interested in this subject and the capabilities NewGene has in this area please get in touch using the contact form at the bottom of the page.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne

Tel: +44 (0)191 241 8769
Fax: +44 (0)191 241 8799

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience


Sophia Genetics



Enquiry form